WallStreetZenWallStreetZen

NASDAQ: VIR
Vir Biotechnology Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for VIR

Based on 7 analysts offering 12 month price targets for Vir Biotechnology Inc

Min Forecast
$14.00+134.11%
Avg Forecast
$33.57+461.39%
Max Forecast
$110.00+1,739.46%

Should I buy or sell VIR stock?

Based on 7 analysts offering ratings for Vir Biotechnology Inc.

Strong Buy
Strong Buy
3 analysts 42.86%
Buy
3 analysts 42.86%
Hold
1 analysts 14.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although VIR's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates VIR as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their VIR stock forecasts and price targets.

VIR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-17
lockedlocked$00.00+00.00%2025-02-28
lockedlocked$00.00+00.00%2025-02-28
lockedlocked$00.00+00.00%2025-02-27
lockedlocked$00.00+00.00%2025-01-13
Morgan Stanley
Bottom 7%
7
Strong BuyUpgrades$20.00+234.45%2025-01-09
JP Morgan
Bottom 4%
4
HoldMaintains$14.00+134.11%2025-01-09

1 of 1

Forecast return on equity

Is VIR forecast to generate an efficient return?

Company
-11.74%
Industry
146.26%
Market
80.85%
VIR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VIR forecast to generate an efficient return on assets?

Company
-9.66%
Industry
36.38%
VIR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VIR earnings per share forecast

What is VIR's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$3.40
Avg 2 year Forecast
-$3.23
Avg 3 year Forecast
-$2.52

VIR revenue forecast

What is VIR's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$61.6M-17.04%
Avg 2 year Forecast
$51.5M-30.54%
Avg 3 year Forecast
$92.6M+24.79%
VIR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VIR revenue growth forecast

How is VIR forecast to perform vs Biotechnology companies and vs the US market?

Company
5.01%
Industry
64.61%
Market
10.18%
VIR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VIR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VIR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VIR$5.98$33.57+461.39%Strong Buy
AVXL$9.63$44.00+356.91%Strong Buy
BCAX$14.88$24.00+61.31%Buy
CVAC$3.53$16.00+353.26%Buy
NTLA$8.20$34.93+325.96%Buy
View Top Biotech Stocks

Vir Biotechnology Stock Forecast FAQ

Is Vir Biotechnology Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: VIR) stock is to Strong Buy VIR stock.

Out of 7 analysts, 3 (42.86%) are recommending VIR as a Strong Buy, 3 (42.86%) are recommending VIR as a Buy, 1 (14.29%) are recommending VIR as a Hold, 0 (0%) are recommending VIR as a Sell, and 0 (0%) are recommending VIR as a Strong Sell.

If you're new to stock investing, here's how to buy Vir Biotechnology stock.

What is VIR's earnings growth forecast for 2025-2027?

(NASDAQ: VIR) Vir Biotechnology's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.73%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.6%.

Vir Biotechnology's earnings in 2025 is -$521,960,000.On average, 6 Wall Street analysts forecast VIR's earnings for 2025 to be -$466,287,172, with the lowest VIR earnings forecast at -$530,744,517, and the highest VIR earnings forecast at -$338,743,916. On average, 6 Wall Street analysts forecast VIR's earnings for 2026 to be -$442,287,097, with the lowest VIR earnings forecast at -$614,401,921, and the highest VIR earnings forecast at -$323,658,155.

In 2027, VIR is forecast to generate -$345,601,081 in earnings, with the lowest earnings forecast at -$438,858,515 and the highest earnings forecast at -$267,429,408.

What is VIR's revenue growth forecast for 2025-2027?

(NASDAQ: VIR) Vir Biotechnology's forecast annual revenue growth rate of 5.01% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.18%.

Vir Biotechnology's revenue in 2025 is $74,205,000.On average, 3 Wall Street analysts forecast VIR's revenue for 2025 to be $8,442,952,116, with the lowest VIR revenue forecast at $1,438,633,070, and the highest VIR revenue forecast at $14,564,616,973. On average, 3 Wall Street analysts forecast VIR's revenue for 2026 to be $7,068,364,960, with the lowest VIR revenue forecast at $1,511,319,012, and the highest VIR revenue forecast at $12,425,181,712.

In 2027, VIR is forecast to generate $12,699,468,284 in revenue, with the lowest revenue forecast at $1,586,747,819 and the highest revenue forecast at $20,736,064,843.

What is VIR's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: VIR) forecast ROA is -9.66%, which is lower than the forecast US Biotechnology industry average of 36.38%.

What is VIR's Price Target?

According to 7 Wall Street analysts that have issued a 1 year VIR price target, the average VIR price target is $33.57, with the highest VIR stock price forecast at $110.00 and the lowest VIR stock price forecast at $14.00.

On average, Wall Street analysts predict that Vir Biotechnology's share price could reach $33.57 by Apr 17, 2026. The average Vir Biotechnology stock price prediction forecasts a potential upside of 461.39% from the current VIR share price of $5.98.

What is VIR's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: VIR) Vir Biotechnology's current Earnings Per Share (EPS) is -$3.83. On average, analysts forecast that VIR's EPS will be -$3.40 for 2025, with the lowest EPS forecast at -$3.87, and the highest EPS forecast at -$2.47. On average, analysts forecast that VIR's EPS will be -$3.23 for 2026, with the lowest EPS forecast at -$4.48, and the highest EPS forecast at -$2.36. In 2027, VIR's EPS is forecast to hit -$2.52 (min: -$3.20, max: -$1.95).

What is VIR's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: VIR) forecast ROE is -11.74%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.